GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.83 $2.75 Thursday, 18th Apr 2024 CGEN stock ended at $1.88. This is 1.05% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.10% from a day low at $1.83 to a day high of $1.96.
90 days $1.80 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
2021-03-19 $8.71 $9.12 $8.52 $9.10 1 315 396
2021-03-18 $9.02 $9.30 $8.59 $8.65 1 313 043
2021-03-17 $8.88 $9.42 $8.58 $9.22 1 733 817
2021-03-16 $9.40 $9.61 $8.71 $9.11 1 273 685
2021-03-15 $9.13 $9.39 $8.85 $9.34 1 283 850
2021-03-12 $8.82 $9.18 $8.50 $8.90 1 162 005
2021-03-11 $8.74 $9.31 $8.54 $9.22 2 224 881
2021-03-10 $8.90 $9.27 $8.37 $8.42 2 576 875
2021-03-09 $8.16 $8.84 $8.13 $8.52 2 452 099
2021-03-08 $8.38 $8.60 $7.60 $7.67 2 149 008
2021-03-05 $8.31 $8.41 $7.10 $8.30 2 849 023
2021-03-04 $8.95 $9.10 $7.80 $8.16 2 323 895
2021-03-03 $9.67 $9.67 $8.66 $8.91 1 586 031
2021-03-02 $10.01 $10.25 $9.34 $9.41 1 174 795
2021-03-01 $9.98 $10.26 $9.73 $9.97 1 903 582
2021-02-26 $9.01 $9.43 $8.50 $9.33 3 244 455
2021-02-25 $10.83 $10.99 $8.83 $8.96 4 187 476
2021-02-24 $10.51 $10.57 $9.96 $10.36 2 339 722
2021-02-23 $11.68 $11.70 $10.00 $10.51 3 043 425
2021-02-22 $13.33 $13.34 $11.48 $11.82 1 922 124
2021-02-19 $12.74 $13.33 $12.74 $12.77 894 237
2021-02-18 $12.84 $12.99 $12.00 $12.56 1 095 883
2021-02-17 $12.95 $13.49 $12.75 $13.21 911 827
2021-02-16 $13.42 $13.86 $13.04 $13.08 1 181 156
2021-02-12 $12.87 $13.23 $12.73 $13.13 643 856
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT